Cargando…

Plasma D-dimer is not useful in the prediction of deep vein thrombosis after total knee arthroplasty in patients using rivaroxaban for thromboprophylaxis

BACKGROUND: Venous thromboembolism (VTE) is a serious complication following total joint replacement. The use of rivaroxaban, a highly selective and direct factor Xa inhibitor, has been used widely as a safe and efficacious way to prevent VTE after total joint replacements. However, little is known...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wu, Cheng-Ta, Chen, Bradley, Wang, Jun-Wen, Yen, Shih-Hsiang, Huang, Chung-Cheng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6042345/ https://www.ncbi.nlm.nih.gov/pubmed/29996862 http://dx.doi.org/10.1186/s13018-018-0883-1

Ejemplares similares

Thromboprophylaxis for Total Knee Arthroplasty
por: Gali, Julio Cesar, et al.
Publicado: (2019)

Comparison of Postoperative Bleeding in Total Hip and Knee Arthroplasty Patients Receiving Rivaroxaban, Enoxaparin, or Aspirin for Thromboprophylaxis
por: Lindquist, Desirae E., et al.
Publicado: (2018)

Topical Tranexamic Acid Reduces Blood Loss in Minimally Invasive Total Knee Arthroplasty Receiving Rivaroxaban
por: Yen, Shih-Hsiang, et al.
Publicado: (2017)

Rivaroxaban for thromboprophylaxis after total hip or knee arthroplasty: a meta-analysis with trial sequential analysis of randomized controlled trials
por: Ning, Guang-Zhi, et al.
Publicado: (2016)

Bleeding complications of thromboprophylaxis with dabigatran, nadroparin or rivaroxaban for 6 weeks after total knee arthroplasty surgery: a randomised pilot study
por: van der Veen, Lucia, et al.
Publicado: (2021)

Thromboprophylaxis for Deep Vein Thrombosis and Pulmonary Embolism after Total Joint Arthroplasty in a Low Incidence Population
por: Kim, Kang-Il, et al.
Publicado: (2013)

The value of D-dimer in the detection of early deep-vein thrombosis after total knee arthroplasty in Asian patients: a cohort study
por: Chen, Chung-Jen, et al.
Publicado: (2008)

A Cohort Study of Rivaroxaban Combined with D-Dimer Dynamic Monitoring in the Prevention of Deep Venous Thrombosis after Knee Arthroplasty
por: Dong, Yongyong, et al.
Publicado: (2022)

The influence of tourniquet use and operative time on the incidence of deep vein thrombosis in total knee arthroplasty
por: Hernandez, Arnaldo José, et al.
Publicado: (2012)

Retracted: A Cohort Study of Rivaroxaban Combined with D-Dimer Dynamic Monitoring in the Prevention of Deep Venous Thrombosis after Knee Arthroplasty
por: Methods in Medicine, Computational and Mathematical
Publicado: (2023)

New Oral Anticoagulants for Thromboprophylaxis after Elective Total Hip and Knee Arthroplasty
por: Friedman, Richard J.
Publicado: (2010)

Patient compliance with deep vein thrombosis prophylaxis after total hip and total knee arthroplasty
por: Wiznia, Daniel H., et al.
Publicado: (2019)

Early treatment outcome of isolated calf vein thrombosis after total knee arthroplasty
por: Yun, Woo-Sung, et al.
Publicado: (2012)

Thrombin antithrombin complex concentration as an early predictor of deep vein thrombosis after total hip arthroplasty and total knee arthroplasty
por: Lin, Zhencan, et al.
Publicado: (2022)

The Efficacy and Safety of Rivaroxaban for Venous Thromboembolism Prophylaxis after Total Hip and Total Knee Arthroplasty
por: Russell, Robert D., et al.
Publicado: (2013)

Deep vein thrombosis and thromboprophylaxis in arthroscopic anterior cruciate ligament reconstruction
por: Adala, Raviraj, et al.
Publicado: (2011)

Risk factors for deep vein thrombosis even using low-molecular-weight heparin after total knee arthroplasty
por: Lee, Joon Kyu, et al.
Publicado: (2021)

Inflammatory Biomarkers as Prognostic Factors of Acute Deep Vein Thrombosis Following the Total Knee Arthroplasty
por: Melinte, Răzvan Marian, et al.
Publicado: (2022)

Robotic-assisted total knee arthroplasty is not associated with increased risk of postoperative deep vein thrombosis
por: Itou, Junya, et al.
Publicado: (2023)

Dabigatran, rivaroxaban, or apixaban versus enoxaparin for thromboprophylaxis after total hip or knee replacement: systematic review, meta-analysis, and indirect treatment comparisons
por: Gómez-Outes, Antonio, et al.
Publicado: (2012)

Venous thromboembolism prophylaxis after total knee arthroplasty (TKA): aspirin vs. rivaroxaban()
por: Colleoni, Jose Luiz, et al.
Publicado: (2017)

Comparison of Enoxaparin and Rivaroxaban in the Prophylaxis of Deep Venous Thrombosis in Arthroplasty
por: Çiçek, Necati, et al.
Publicado: (2021)

Usefulness of a novel method for the screening of deep vein thrombosis by using a combined D-dimer- and age-based index before total hip arthroplasty
por: Imai, Norio, et al.
Publicado: (2017)

Total Knee Arthroplasty in a Diagnosed Case of Deep Vein Thrombosis - Our Experience and Review of Literature
por: Agarwal, Saurabh, et al.
Publicado: (2017)

Superficial femoral artery pseudoaneurysm, compartment syndrome, and deep vein thrombosis after total knee arthroplasty
por: Sánchez, Carlos A., et al.
Publicado: (2020)

Efficacy and risks of fondaparinux 7.5 mg for deep vein thrombosis after total knee arthroplasty
por: Nojiri, Sho, et al.
Publicado: (2019)

A multi-perspective cost-effectiveness analysis comparing rivaroxaban with enoxaparin sodium for thromboprophylaxis after total hip and knee replacement in the German healthcare setting
por: Zindel, Sonja, et al.
Publicado: (2012)

Preoperative Evaluation of Soleal Vein Diameter by Ultrasound Is Beneficial for Prophylaxis of Deep Vein Thrombosis after Total Knee or Hip Arthroplasty
por: Yao, Yao, et al.
Publicado: (2018)

History of COVID-19 infection is not associated with increased d-dimer levels and risk of deep-vein thrombosis in total joint arthroplasty
por: Jungwirth-Weinberger, Anna, et al.
Publicado: (2021)

Combined use of topical intraarticular tranexamic acid and rivaroxaban in total knee arthroplasty safely reduces blood loss, transfusion rates, and wound complications without increasing the risk of thrombosis
por: Kim, Yong Tae, et al.
Publicado: (2018)

Rivaroxaban and Acetylsalicylic Acid for Prevention of Venous Thromboembolism Following Total Knee Arthroplasty in Korean Patients
por: Chung, Kyu Sung, et al.
Publicado: (2018)

Is Routine Thromboprophylaxis Needed in Korean Patients Undergoing Unicompartmental Knee Arthroplasty?
por: Koh, In Jun, et al.
Publicado: (2016)

Recurrent acute portal vein thrombosis in liver cirrhosis treated by rivaroxaban
por: Yang, Hyeyoung, et al.
Publicado: (2016)

Use of oral rivaroxaban in cerebral venous thrombosis
por: Maqsood, Muhammad, et al.
Publicado: (2020)

Skin Necrosis Associated with Thromboprophylaxis after Total Knee Replacement
por: Karuppiah, S. V., et al.
Publicado: (2014)

Perioperative allogenic blood transfusion increases the incidence of postoperative deep vein thrombosis in total knee and hip arthroplasty
por: Jiang, Tao, et al.
Publicado: (2019)

Chronic Kidney Dysfunction Can Increase the Risk of Deep Vein Thrombosis after Total Hip and Knee Arthroplasty
por: Li, Qiangqiang, et al.
Publicado: (2017)

Construction of Prediction Model of Deep Vein Thrombosis Risk after Total Knee Arthroplasty Based on XGBoost Algorithm
por: Chen, Yuhuan, et al.
Publicado: (2022)

Preferences and Practices of Brazilian Orthopedists for Thromboprophylaxis Techniques in Total Knee Arthroplasty: Survey Among Members of the Brazilian Society of Knee Surgery (SBCJ)
por: Maradei-Pereira, João Alberto Ramos, et al.
Publicado: (2022)

Benefit–Risk Assessment of Rivaroxaban for Extended Thromboprophylaxis After Hospitalization for Medical Illness
por: Raskob, Gary E., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_5521cso731kli3aorkl6i8au7n